DRKS00017057已完成不适用
Trial to Characterize and Grade the Severity of Capillary Leak Syndrome in Cardiovascular Surgery - Cardio-CLS
Klinik für Anästhesiologie und Intensivmedizin, Uniklinik Freiburg0 个研究点目标入组 405 人开始时间: 2019年4月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 405
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Cardiac and/or vascular surgery
- •2. Age =18
- •3. Consent of the patient, of next-of-kin or legal guardian
排除标准
- •1. Refusal to participate of the patient, of next-of-kin or legal guardian
- •2. Idiopathic Capillary Leak Syndrome (ICLS, Clarkson's Disease)
- •3. HIV infection
- •4. Viral hepatitis
- •5. Hereditary C1-esterase deficiency
- •6. Recurrent Angioedema
- •7. Pre-existing chronic kidney failure on requiring dialysis
- •8. Pre-existing hepatic impairment with MELD score = 20
- •9. Participation in pharmacological trials
研究者
相似试验
尚未招募
不适用
To study the characteristics and outcomes of cancer patients with coronavirus (Covid 19) admitted to the intensive care unit in a Cancer CentreCTRI/2021/06/034301Tata Memorial Hospital
尚未招募
不适用
Features of bone pain in cancer patientsCTRI/2021/10/037331Tata Memorial Hospital
尚未招募
3 期
How Calcarea carbonica 200c Homoeopathic Medicine works in Pain Management of Knee Joint in Osteoarthritis among Women aged 45-65 YearsCTRI/2023/02/049604Dr.Sailee Mysker
尚未招募
2 期
Role of Homoeopathic medicines in treatment of children with worms.CTRI/2024/03/063707Raxitkumar Ramavat
招募中
1 期
Phase Ib/III Study of Capivasertib + CDK4/6 Inhibitors + Fulvestrant as Treatment for Advanced/Metastatic HR+/HER2-Breast Cancer (CAPItello-292)Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast CancerCTIS2023-504997-39-00AstraZeneca AB629